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Pérdida auditiva neurosensorial después de sufrir meningitis bacteriana en niños
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his study is dedicated to identifying the compli-
cations of sensorineural hearing loss (SHL) after 
bacterial meningitis (BM) in children to optimize 
diagnosis and timely treatment. Complications of senso-
rineural hearing loss (SHL) after bacterial meningitis (BM) 
in children were studied using screening observation of 
patients who had BM from 2015 to 2018. A cohort study 
was conducted to detect CHT in patients with meningitis 
after discharge with the mandatory audiological exami-
nation. Out of all 167 treated children, 103 children un-
derwent an audiological examination, with a diagnosis of 
“Bacterial meningitis” – 60.7% (n = 65) and “Enterovirus 
meningitis” - 73.3% (n = 52). Patients were monitored 
for 1 year, the corresponding clinical history data, a di-
agnostic procedure, preoperative imaging data, the time 
interval between the diagnosis of bilateral deafness and 
cochlear implantation, computed tomography data with 
fibrosis or ossification were taken. Evaluation of hearing 
was evaluated based on the latest available results of pure 
tone and speech audiometry for children.
Keywords: meningitis, sensorineural hearing loss, ac-
quired deafness, cochlear implantation, children.
ste estudio está dedicado a identificar las 
complicaciones de la pérdida auditiva neuro-
sensorial (SHL) después de la meningitis bac-
teriana (BM) en niños para optimizar el diagnóstico y el 
tratamiento oportuno. Las complicaciones de la pérdida 
auditiva neurosensorial (SHL) después de la meningitis 
bacteriana (BM) en niños se estudiaron mediante la ob-
servación de detección de pacientes con BM de 2015 a 
2018. Se realizó un estudio de cohorte para detectar CHT 
en pacientes con meningitis después del alta con examen 
audiológico obligatorio. De los 167 niños tratados, 103 
niños se sometieron a un examen audiológico, con un 
diagnóstico de “meningitis bacteriana”: 60,7% (n = 65) 
y “meningitis por enterovirus”: 73,3% (n = 52). Los pa-
cientes fueron monitoreados durante 1 año, se tomaron 
los datos de la historia clínica correspondiente, un proced-
imiento de diagnóstico, datos de imágenes preoperato-
rias, el intervalo de tiempo entre el diagnóstico de sordera 
bilateral y la implantación coclear, datos de tomografía 
computarizada con fibrosis u osificación. La evaluación de 
la audición se evaluó sobre la base de los últimos resulta-
dos disponibles de tono de pureza y audiometría del habla 
para niños.
Palabras clave: meningitis, hipoacusia neurosensorial, 
sordera adquirida, implantación coclear, niños.
t is estimated, that the annual frequency of bacterial 
meningitis (BM) in the western world is 2–5 cases per 
100 000 populations1. This indicator in less developed 
countries can be 10 times higher. BM worldwide takes one 
of the first positions in the list of 10 causes of deaths, asso-
ciated with infectious diseases, 30–50% of survivors have 
neurological consequences that persist for a long time2.
The use of the pneumococcal conjugate vaccine (PCV13) 
in the national immunization schedule also resulted in a 
decrease in the incidence of pneumococcal meningitis in 
countries with an active immunization program3. It should 
be noted, that in Kazakhstan from 2010 to 2015 began to 
introduce phased vaccination with an anti-pneumococcal 
conjugate vaccine (PCV13)4.
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According to foreign scientists LuksicI, MulicR, Falconer 
R (2013), the incidence of BM and its etiology cannot be 
objectively assessed globally due to the lack of etiologi-
cal interpretation and incomplete statistics5. According to 
official statistics, a similar situation is observed in Kazakh-
stan, there is general information about the incidence of 
BM, without identifying the etiological factor, as a result 
of which there is practically no epidemiological surveil-
lance system and there is no official registration of BM. 
According to statistics, monitoring the incidence of BM in 
Kazakhstan from 2012 to 2017 is characterized by vari-
ability of indicators, for 6 years, an average of 2.17% 
per 100 thousand children (900 cases). The highest peak 
in the incidence of BM in Kazakhstan as a whole was in 
2014, 5.52% (242 cases). In subsequent years, there was 
a tendency to decrease in this indicator: by 2015 - by 1.2 
times, and by 2016 - by 1.3 times, at the end of 2017, 
the incidence rate of BM (compared to 2014) decreased 
- 2.5 times6,7.
According to Bhasin T.K. et al. (2006), BM causes partial 
or complete hearing loss in 10–20% of cases8. The fre-
quency of hearing loss after suffering BM is different, for 
the causative agents of N. meningitides - 8–11%, H. in-
fluenza - 6–11% of cases9. Also, the risk of hearing the 
loss in BM caused by S. pneumonia is 22% and 8% in N. 
meningitidis10,11. The problems of hearing impairment in 
BM are the most common, whereas they are not observed 
in viral meningitis12. In 25–30% of cases in children, who 
have undergone BM, a hearing loss is not detected in a 
timely manner13. It is especially difficult to diagnose “sen-
sorineural hearing loss” in children under 3 years of age 
since their hearing impairment can be detected in a late 
period either by parents or during a specialized examina-
tion. Hearing loss affects the development of speech and 
psychomotor development of the child14.
Aim of the Study: To identify the complication of senso-
rineural hearing loss after suffering bacterial meningitis 
in children to optimize early diagnosis, prevention, treat-
ment, and rehabilitation.
he study was conducted as part of the research 
project “Development of Early Diagnostics and 
Preventive Measures of Hearing Impairment 
after Suffering from Bacterial Meningitis in Children” 
AP05135091 implemented under grant funding at the 
clinic in the City Children’s Infectious Diseases Hospital, 
Astana, in the center “Life Sciences” NU, “National Labo-
ratory Astana” from 2015 to 2018.
A cohort study was conducted to detect SHL in patients 
with meningitis after discharge with the mandatory audi-
ological examination. Out of all 167 treated children, 103 
children underwent an audiological examination, with a 
diagnosis of “Bacterial meningitis” – 60.7% (n = 65) and 
“Enterovirus meningitis” - 73.3% (n = 52). Patients were 
monitored for 1 year, the corresponding clinical history 
data, a diagnostic procedure, preoperative imaging data, 
the time interval between the diagnosis of bilateral deaf-
ness and cochlear implantation, computed tomography 
data with fibrosis or ossification were taken. Evaluation of 
hearing was evaluated based on the latest available results 
of pure tone and speech audiometry for children14.
7 patients of all patients, treated with meningitis, had 
mild, moderate, severe, or bilateral deep SHL after bac-
terial meningitis. Therefore, we describe only these pa-
tients (n-7). All patients (n-7) received a vaccine against 
Haemophilus influenza, one patient against Streptococcus 
pneumonia. All patients showed normal hearing develop-
ment before the onset of meningitis. All patients had nor-
mal physical and psychological development during the 
onset of meningitis. All patients underwent a complete 
neurological and otolaryngological assessment. The etiol-
ogy of meningitis was determined by the culture of cere-
brospinal fluid. The audiological assessment consisted of 
auditory brainstem response (ABR) and otoacoustic emis-
sions (OAE) and, if possible, short-latency auditory evoked 
potentials (SAEP). Besides, all patients underwent an X-ray 
evaluation, consisting of a high-resolution computed to-
mography (HRCT) of the middle ear. One patient under-
went cochlear implantation (CI).
Statistical data processing was performed by a statistical 
method using the SPSS IBM Statistiсs 20 program. Methods 
of descriptive statistics and logistic regression were used.
n the study of all studied patients, the leading role 
in the etiological structure of BM was N. menin-
gitides - 76.4% (n=68), S. pneumonia, - 14,6% 
(n=13), and isolated cases of pathogens in the form of 
S. pyogenes, S. agalactiae and S. aureus - 1.2% (n=1), 
respectively (Figure 1). 
By dint of a screening study using a complex of audiol-
ogy research methods - OAE, SAEP, and audiometry, a 
decrease in auditory function was detected in 7 children, 
who underwent BM (Table 1).
Of all examined children with BM (n=65), hearing loss was 
detected in 10.7% (n=7). According to the parents, no 
child’s hearing impairment was noted before the disease. 
The age structure of the studied groups: children from 
0 to 11 months, from 12 to 59 months with a uniform 
distribution of patients, who accounted for - 42.8% in 
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both groups (n=6), the remaining children over 5 years old 
–14.4% (n=1). All children received vaccination against 
Hib, and only one child against S. pneumoniae (PCV13) 
(cases 7). Among children with hearing impairment, 
pneumococcal meningitis – 71.4% (n=4), in contrast to 
meningococcal meningitis - 28.6% (n=3), comes to the 
forefront in etiological aspect. No patient with enterovirus 
meningitis (n=52) was found to have impaired auditory 
function after an illness.
In all patients, SHL was detected during follow-up obser-
vation. However, when interviewing the parents of one 
of the patients (cases 6), complaints of hearing loss were 
noted already during inpatient treatment, in the remaining 
85.7% of patients (n=6) for a different period - 6.1±0.2 
months (from 20 days to 24 months) after discharge from 
the hospital.
In the children we studied, SHL 1st–2nd degrees (right and 
left ear) were detected in 28.5% (n=2) followed by obser-
vation by audiologist, SHL 2nd–1ts and 4th–2nd degrees 
in 28.6% (n=2), respectively, and SHL of 3rd-4th degrees 
with ossification of the cochlea on CT of the temporal 
bones in 28.5% with pneumococcal meningitis (n=2) and 
without ossification of the cochlea in 14.3% (n=1). Pa-
tient 3 complained of hearing loss late (24 months) and at 
the outpatient stage, during the examination, there were 
contradictory diagnoses: the audiologist was diagnosed 
with “Sensorineural hearing loss?”, and CT scan showed 
no pathological changes in the temporal bones. When 
re-examining a CT scan, another doctor has already con-
cluded: “Bilateral sensorineural hearing loss of 4th degree 
with ossification of the cochlea”. Also, in another child 
(cases – 4) with complaints of hearing loss, which turned 
14 months after the disease, during the examination, SHL 
of 3rd–4th degrees were exposed with ossification of the 
cochlea. Due to the development of ossification of the 
cochlea of  the inner ear, 2 patients failed to undergo a CI. 
These patients (42.8%) received a disability of group 3.
In the next patient (cases – 5), SHL of 3rd–4th degrees 
were detected after 20 days, CT imaging demonstrated co-
chlear fibrosis, and this patient was a candidate for emer-
gency CI. The patient was held CI after 50 days in Astana.
The rest of the patients (cases 1, 2, 6, 7) were recom-
mended auditory prosthetics (binaural).
Table 1. The results of hearing impairment in children after suffering BM.
Patient Microorganism Age
The interval between 
meningitis and SHL 
(days)
Degree of SHL
(right and left ear)
The presence 
of ossification 
on CT
Medical Conclusion 
(recommendations)
1 N.meningitidis 11 years, 16 days 60 1–2 «–» audiologist observationauditory prosthetics
2 S.pneumonae 8 months 91 1–2 «–» audiologist observationauditory prosthetics
3 S.pneumonae 5 years 300 3rd–4th degrees «+» audiologist observation
4 S.pneumonae 10 months 334 3 –4 «+» audiologist observation
5 N.meningitidis 1 year, 4 months 20 3–4 «–»
audiologist observation.
recommended cochlear 
implantation
6 S.pneumonae 4 months 90 SHL 4–2 «–» auditory prosthetics recommended
7 N.meningitidis 4 months 30 2–1 «–» auditory prosthetics recommended
Figure 1. The etiological structure of bacterial meningitis in children for 2015-2018 in Astana.
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At the next stage of the study, a binary logistic regres-
sion method was used to identify the factors that lead to 
hearing loss.
After the inclusion of all factors into the model, a statisti-
cally significant indicator was established (p≥0.001). The 
final likelihood ratio tests, which show, that the greatest 
significance among the factors in this model was influ-
enced by such significant indicators as late admission to 
the hospital (p≥0.001), late untimely diagnosis (p≥0.001), 
administration of dexamethasone after the first dose of 
antibiotic (p≥0.001), bacterial etiology of meningitis: PM 
(p≥0.001) and MM (p≥0.05), Nagelkerk coefficient was 
–0.736 (73%).
Regression analysis showed, that hearing loss is observed 
only after BM has been transferred, and in the case of viral 
meningitis, in particular, enterovirus meningitis etiology, 
hearing loss was not detected in any of the cases.
The development of hearing impairment in the late diag-
nosis of BM, where the chance is measured from 0 to 1, 
that is, 1 unit indicates the probability of an event occur-
ring (Figure 2). As a result of the statistical calculation of 
the binary logistic regression, it was found, that the risk 
of developing hearing loss increases with late treatment 
at the hospital. If the patient turns on day 2 of the illness, 
then the probability of developing a hearing loss is - 10% 
(0.1), if on day 3 of the disease – 30% (0.3), on day 4 of 
the illness – 60% (0.6), on day 5 – 85% (0.85), on day 6 
of the disease –95% (0.95).
Table 2. The results of building a binary logistic regression model.
Consequences: diminished hearing 
В(n) Std. Error Wald Dgr. Of sv. Value.
95% CI for Exp (B)
Lower 
bound
Upper 
bound
Free member 28,928 1288,9 ,001 1 ,982
Degree of severity 24,36 12566 0,5 1 ,781 ,125 288
Premorbid background 12,25 1545 054 ,511 ,28 15
Appeal to hospital 15,746 901,01 511,000 1 ,005 0,001 .b
Late diagnosis 2,477 2,054 1454,000 1 ,000 ,213 667,526
Number of bed – days 1,084 1,469 ,544 1 ,001 ,166 52,660
full term or not full term 0c 0
dexamethasone after 1 dose of antibiotic 13,548 2,744 ,849 1 0,001 ,289 32,789
1-11 months 15,569 1090,4 ,000 1 ,005 0,000 .b
12–59 months 1,800 1,979 ,083 1 ,030 ,003 7,990
5–14 years 0c 0
PM 14,736 687,27 ,190 1 ,001 0,001 .b
MM 15,178 687,27 ,750 1 ,001 0,05 .b
EM 0c 0
Figure 2. Development of hearing impairment depending on the length of hospitalization in children with BM.
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BM is the most common cause of acquired hearing loss 
in children and the cause of SHL in adulthood15. In the 
literature, there are various data on the frequency of oc-
currence of hearing impairment after BM. In patients with 
bacterial meningitis, a constant from 5% to 35% of SHL 
develops and the consequences result in deep bilateral 
hearing loss in 4% of patients16. Thus, according to A. Da-
vis and K. Davis (USA, 2011), hearing loss varies between 
2–31%17, although the data from L.J. Baraff (USA)18 
suggests that the incidence with persistent hearing loss 
is closer to 10%. In our case, the SHL after the BM was 
9.3% of all cases (n=65) (n=7), of which the total loss was 
57% (n=4) and SHL of 1st-2nd degrees (n=3).
The final diagnosis of SHL 4th degree was established on 
average 140 days after an episode of meningitis in 3 of 7 
patients (cases 3 through 5), which is much later than the 
timeline described in the literature: 4–28 days. Therefore, 
infectious disease physicians, pediatricians, and general 
practitioners should be fully aware of this complication, 
and it is mandatory to recommend consultation of an au-
diologist to children, who have had meningitis19.
Studies in patients with sensorineural hearing loss con-
ducted in 2010 by D. Philippon, et al. using CT of tem-
poral bones found, that a more pronounced degree of 
ossification of the cochlea is more often determined after 
suffering meningitis caused by S. pneumoniae20. In our 
series, CT scan of the temporal bones revealed the os-
sification of the cochlea in three patients and cochlea 
fibrosis in one patient. Patients with ossification of the 
cochlea addressed very late periods (900; 300; 334 days). 
The use of corticosteroids (dexamethasone) before an-
tibiotic therapy in bacterial meningitis reduces the risk 
of cochlear ossification21. The meta-analysis evaluated 
the value of dexamethasone in the treatment of bac-
terial meningitis: dexamethasone did not reduce the 
mortality or incidence of neurological lesions, but the 
risk of deafness was lower in surviving patients22. How-
ever, SHL is not always clinically detected, so the hear-
ing loss may not be diagnosed for a long period of 
time23. All the patients we observed, dexamethasone 
was obtained after the administration of the antibiotic. 
In our country, the lack of consultation of a specialist audi-
ologist in the clinical protocol for diagnosis and treatment 
of BM is fraught with late detection of SHL in a child, 
which ends with ossification and the inability to perform 
a cochlear implant and, as a result, leads to disability of a 
child with complete hearing impairment.
The problems of hearing impairment in BM are the most 
common, whereas they are not observed in viral menin-
gitis24. Also, the results of our study confirmed that in the 
case of enteroviral meningitis SHL no cases were detected. 
When BM in the inner ear there are significant pathologi-
cal changes, the final stage of which is the development 
of ossification of the cochlea. The process of development 
of the ossification of the cochlea consists of three stages: 
acute, fibrous, and the stage of ossification. The acute 
phase coincides with the onset of meningitis and is char-
acterized by purulent inflammation and the formation of 
serous-fibrous exudate mainly in the perilymphatic space, 
without affecting the cavity filled with endolymph25. Af-
ter 2 weeks from the beginning of the infection process, 
the second stage of neurosensory hearing loss develops 
- fibrous, which is accompanied by a proliferation of fi-
broblasts in the perilymphatic spaces, then angiogenesis 
begins. The third stage of neurosensory hearing loss ends 
with ossification proper26. At the stage of ossification, 
bone tissue is formed, which is primarily found in the bas-
al curl, starting from the second month after the develop-
ment of the labyrinthitis. The formation of bone tissue, 
followed by calcification and remodeling, obliterates both 
peri-and endolymphatic prostration. Therefore, before the 
first stage of the ossification of the cochlea in BM, it is 
necessary to detect SHL as soon as possible to recommend 
cochlear implantation to patients27. In our case, two pa-
tients with complete hearing loss were examined late in 
300 and 334 days at the ossification stage, therefore, they 
did not undergo CI. It is especially difficult to diagnose 
“sensorineural hearing loss” in children under 3 years of 
age since their hearing impairment can be detected in a 
late period either by parents or during a specialized exami-
nation. Hearing loss affects the development of speech 
and psychomotor development of the child28,32-34.
Ossification of the cochlea can progress and jeopardize 
the success of cochlear implantation12. The limited capa-
bilities of the high-tech assistance system, such as, for 
example, in our country, as well as the remoteness of pa-
tients from the CI centers, do not always allow for surgical 
intervention in such a short time.
Also, it should be borne in mind, that at the present stage, 
the prevention of the development of disability in the 
form of complete hearing loss after BM can be ensured 
only by surgical intervention in the form of a cochlear im-
plant. Moreover, the earlier implantation of the cochlear 
apparatus to the patient, i.e. before the formation of the 
2nd and 3rd stages of ossification of the cochlea, will al-
low to fully restore hearing29,30.
n the etiological structure of BM complicated by 
hearing impairment in children, pneumococci 
dominated (71.4%). All children with hearing im-
pairment were not vaccinated against pneumococcus and 
meningococcus (100%) and dexamethasone injection 
was administered after the first dose of antibiotic (100%). 
Statistical analysis of logistic regression revealed, that with 
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late treatment, late diagnosis and the presence of bacte-
rial meningitis there is a high risk of developing hearing 
impairment.
We propose the following observation protocol: all pa-
tients after suffering bacterial meningitis should be pre-
scribed audiologic tests for 1 year. Audiometry should be 
repeated 1,3,6,9 and 12 months.
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